3660

Improved assessment of prostate-cancer bone metastases through multicompartmental analysis of whole-body DWI data
Christopher C Conlin1, Christine H Feng2, Leonardino A Digma2, Ana E Rodriguez-Soto1, Joshua M Kuperman1, Dominic Holland3, Rebecca Rakow-Penner1, Tyler M Seibert1,2,4, Michael E Hahn1, and Anders M Dale1,3,5
1Department of Radiology, UC San Diego School of Medicine, La Jolla, CA, United States, 2Department of Radiation Medicine and Applied Sciences, UC San Diego School of Medicine, La Jolla, CA, United States, 3Department of Neurosciences, UC San Diego School of Medicine, La Jolla, CA, United States, 4Department of Bioengineering, UC San Diego Jacobs School of Engineering, La Jolla, CA, United States, 5Halıcıoğlu Data Science Institute, UC San Diego, La Jolla, CA, United States

Synopsis

Whole-body DWI is increasingly used to assess bone involvement in prostate cancer. Multicompartmental diffusion modeling can outperform conventional DWI techniques for evaluating tumors, but has yet to be applied to whole-body imaging. In this study, we determined an optimal multicompartmental model for describing whole-body diffusion and applied it to examine metastatic bone lesions in vivo. We found that a 4-compartment model best characterized whole-body diffusion. Compartmental signal-contributions revealed by this model show improved bone-lesion conspicuity and may help to assess microstructural changes that accompany prostate-cancer bone involvement.

Motivation

Whole-body MRI is increasingly being used to detect bone involvement in prostate cancer.1 Diffusion-weighted imaging (DWI) and apparent diffusion coefficient (ADC) mapping are important components of the multiparametric approach recommended for whole-body metastasis screening.2 Recent studies have shown that multicompartmental diffusion modeling outperforms these conventional DWI techniques for assessing cancer within the prostate,3 but such modeling has yet to be applied to whole-body imaging.

In this study, we optimized a multicompartmental model for describing diffusion signal throughout the body and applied it to examine the diffusion characteristics of metastatic bone lesions in vivo. The potential clinical utility of this model was examined by comparing lesion conspicuity on model-derived images against their conspicuity on conventional DWI.

Methods

This prospective study included 30 patients with prostate cancer who underwent an extended whole-body MRI examination in addition to routine clinical imaging. Standard-of-care evaluation identified 107 bone lesions in 25 of these patients.

Whole-body MRI acquisition
MR imaging was performed on a 3T clinical scanner (Discovery MR750; GE Healthcare). Five stations were imaged for each patient, corresponding roughly to the head, chest, abdomen, pelvis, and thighs. At each station, an axial volume of multi-shell diffusion data was acquired using 4 b-values: 0, 500, 1000, and 2000 s/mm2, sampled at 1, 6, 6, and 12 unique diffusion-encoding gradient directions, respectively (default tensor, TR: 4750ms, TE: 75ms, matrix: 80×80 resampled to 128×128, FOV: 400mm, slices: 46, slice thickness: 6mm). For anatomical reference, a high resolution T2-weighted volume was also acquired at each station with scan-coverage identical to that of the multi-shell DWI volume (TR: 1350ms, TE: 113ms, matrix: 384×224 resampled to 512×512, FOV: 400mm, slices: 46, slice thickness: 6mm).

MRI data post-processing
Each multi-shell DWI volume was first corrected for distortions due to B0-inhomogeneity, gradient nonlinearity, and eddy currents.4 The signal intensity of each DWI volume was corrected to account for noise.5 Isotropic diffusion was assumed, so directional DWI volumes at each b-value were averaged. Conventional ADC maps were computed by fitting the DWI data to a monoexponential signal model.6

Regions of interest (ROIs) were defined on the DWI volumes. Whole-body ROIs (excluding the head) were defined for 10 patients. In 5 patients without metastases, tissue-specific ROIs were defined in the pelvic and thigh stations (to avoid respiratory motion artifacts), specifically over the bladder (including urine), prostate, testes, and subcutaneous fat. In 25 patients, ROIs were defined over each identified bone lesion.

Multicompartmental modeling and analysis
Restriction spectrum imaging (RSI) is a multicompartmental modeling framework that describes the DWI signal thusly: $$S(b)=\sum_{i=1}^{K}C_ie^{-bD_i}$$ where S(b) denotes the noise-corrected DWI signal at a particular b-value, K is the number of tissue compartments, Ci describes the contribution of a particular compartment to the overall signal, and Di is the compartmental diffusion coefficient. A global fitting of this model to the DWI data within the 10 whole-body ROIs (~9 million voxels) was performed,3 with K ranging from 2 to 4. The relative Bayesian Information Criterion (ΔBIC7) and model-fitting residual of each model was recorded to evaluate how well it described the whole-body DWI data. Fitting residual was also examined at the voxel-level and ROI-level within specific tissues to examine how the fit of each model varied between anatomical regions.

For the optimal RSI model (the model with lowest ΔBIC), signal-contribution (Ci) maps were computed for each patient via nonnegative least-squares fitting of the model to the signal-vs-b-value curve from each voxel.3

Compartmental signal fractions for the optimal model were computed by normalizing the C value of each compartment by the sum of all C values: $$$C_i/\sum_{i=1}^{K}C_i$$$. Signal fractions were compared between bone lesions and other tissues using two-sample t-tests (α=0.05).

Lesion conspicuity
Bone-lesion conspicuity8 was defined as the mean signal within the lesion ROI divided by the mean signal within a control ROI defined by reflecting the lesion ROI laterally across the spine. Conspicuity was calculated for each lesion on the conventional DWI images, ADC map, and signal-contribution maps from the optimal RSI model. Paired t-tests (α=0.05) were used to determine if lesion conspicuity was significantly higher on RSI maps compared to conventional images.

Results

The lowest BIC and model-fitting residuals were observed from the 4-compartment model (Figures 1 and 2). Optimal D values for the 4-compartment model were 0, 1.2e-3, 2.9e-3, and >3.0e-2mm2/s. Signal-contribution (Ci) maps computed using this model are shown in Figure 3 for a patient with bone lesions, alongside conventional MR images. Figure 4 illustrates the significant increase in lesion conspicuity on RSI C1 and C2 maps compared to conventional ADC maps (C1: P<0.001, C2: P=0.02) or DWI images (C1: P<0.001, C2: P<0.04). Figure 5 shows that compartmental signal fraction was significantly higher in compartments 1 (P<0.04) and 2 (P<0.01) of lesions than in other tissues.

Discussion

An optimized 4-compartment RSI model provides a more comprehensive characterization of whole-body diffusion than conventional DWI methods. Compartmental signal-contributions revealed by this model may help to assess microstructural changes that accompany prostate-cancer bone involvement. Improved conspicuity of lesions on RSI signal-contribution maps may help to discriminate between cancerous and benign tissues during whole-body cancer screening.

Acknowledgements

Funding provided by:

Department of Defense Congressionally Directed Medical Research Program. Grant Number: DoD W81XWH‐17‐1‐0618

Prostate Cancer Foundation

National Institute of Biomedical Imaging and Bioengineering. Grant Number: K08 EB026503

References

1. Larbi A, Omoumi P, Pasoglou V, et al.: Whole-body MRI to assess bone involvement in prostate cancer and multiple myeloma: comparison of the diagnostic accuracies of the T1, short tau inversion recovery (STIR), and high b-values diffusion-weighted imaging (DWI) sequences. Eur Radiol 2019; 29:4503–4513.

2. Padhani AR, Lecouvet FE, Tunariu N, et al.: METastasis Reporting and Data System for Prostate Cancer: Practical Guidelines for Acquisition, Interpretation, and Reporting of Whole-body Magnetic Resonance Imaging-based Evaluations of Multiorgan Involvement in Advanced Prostate Cancer. Eur Urol 2017; 71:81–92.

3. Conlin CC, Feng CH, Rodriguez‐Soto AE, et al.: Improved Characterization of Diffusion in Normal and Cancerous Prostate Tissue Through Optimization of Multicompartmental Signal Models. J Magn Reson Imaging (Early View).

4. Holland D, Kuperman JM, Dale AM: Efficient correction of inhomogeneous static magnetic field-induced distortion in Echo Planar Imaging. NeuroImage 2010; 50:175–183.

5. Karunamuni RA, Kuperman J, Seibert TM, et al.: Relationship between kurtosis and bi-exponential characterization of high b-value diffusion-weighted imaging: application to prostate cancer. Acta Radiol 2018; 59:1523–1529.

6. Vidić I, Egnell L, Jerome NP, et al.: Modeling the diffusion-weighted imaging signal for breast lesions in the b = 200 to 3000 s/mm2 range: quality of fit and classification accuracy for different representations. Magn Reson Med 2020; 84:1011–1023.

7. Schwarz G: Estimating the Dimension of a Model. Ann Stat 1978; 6:461–464.

8. White NS, McDonald CR, Farid N, Kuperman JM, Kesari S, Dale AM: Improved Conspicuity and Delineation of High-Grade Primary and Metastatic Brain Tumors Using “Restriction Spectrum Imaging”: Quantitative Comparison with High B-Value DWI and ADC. Am J Neuroradiol 2013; 34:958–964.

Figures

Figure 1: Relative Bayesian Information Criterion (ΔBIC) and model-fitting residual describing the overall fit of each model to whole-body diffusion data. Each bar shows the ΔBIC or residual of a model fit to all voxels within the 10 whole-body ROIs. Lower ΔBIC or residual indicates a better fit to the data, suggesting that the 4-compartment model provides the best characterization of diffusion throughout the body. “Mono” refers to the monoexponential model used for conventional ADC mapping.

Figure 2: Model-fitting residual at the voxel- and ROI-level. The top row shows voxel-wise maps of fitting residual in a coronal plane of the same patient using different models. A T2-weighted image of the same plane is included for reference. The bottom figure graphs the fitting residual within all lesion and tissue-specific ROIs. A better fit to the data was observed with the 4-compartment RSI model than with the conventional monoexponential model or the lower-order RSI models.

Figure 3: Coronal whole-body images of a patient with metastatic bone lesions in the pelvis and femur (red arrows). Conventional MR images are shown in the top row. The bottom row shows the signal-contribution (Ci) maps for the optimized 4-compartment RSI model. The corresponding Di of each model compartment is listed in parentheses next to the compartment label.

Figure 4: Box plots describing bone-lesion conspicuity on conventional DWI images and compartmental signal-contribution (Ci) maps of the optimized 4-compartment RSI model. A red asterisk (*) indicates significantly greater lesion conspicuity compared to conventional ADC maps. Red double daggers (‡) denote significantly greater lesion conspicuity compared to DWI images at any b-value.

Figure 5: Compartmental signal fractions of different tissues for the optimized 4-compartment RSI model. The height of each bar indicates the mean signal fraction across all subjects, with the overlaid error bar indicating the standard deviation. An asterisk (*) over a bar indicates that the signal fraction in this compartment is significantly higher in bone lesions compared to any of the other tissues examined.

Proc. Intl. Soc. Mag. Reson. Med. 29 (2021)
3660